Zobrazeno 1 - 10
of 371
pro vyhledávání: '"Rm, Bertina"'
Publikováno v:
Universal Journal of Pharmaceutical Research.
Objective: Protein C, a vitamin K-dependent coagulation factor, is involved in blood coagulation. Activated protein C inactivates Va and VIIIa and stimulates fibrinolysis. In this process, protein S serve as an important factor for activated protein
Autor:
RM Bertina, HK Ploos van Amstel, A van Wijngaarden, J Coenen, MP Leemhuis, PP Deutz-Terlouw, IK van der Linden, PH Reitsma
Publikováno v:
Blood. 76:538-548
We recently developed an enzyme-linked immunosorbent assay (ELISA) for total protein S (PS) antigen using the monoclonal antibody S-12. During the screening of thrombophilic patients we identified a patient, who was using marcoumar, with 0% PS by mon
Publikováno v:
Europe PubMed Central
The factor V Leiden mutation (FVL) leads to a seven-fold increased risk of venous thromboembolism (VTE). In thrombophilic families. 25% of carriers have experienced thrombosis before the age of 40 years. Aim of our study was to assess the association
Publikováno v:
Europe PubMed Central
Factor VIII activity (factor VIII:C) levelsor =150 IU/dl are associated with a 5- to 6-fold increased risk of venous thrombosis compared to levels100 IU/dl, and fibrinogen levelsor =5.0 g/l increase the thrombosis risk 4-fold. These high levels are p
Publikováno v:
Europe PubMed Central
Comparison of the effect of oral contraceptives on hemostatic variables in venous thrombosis patients (thrombosis while using oral contraceptives) with the effect in healthy control subjects. Our aim was to assess whether some of these effects were m
Autor:
Pw, Kamphuisen, Jeanine Houwing-Duistermaat, Hc, Houwelingen, Jc, Eikenboom, Rm, Bertina, Fr, Rosendaal
Publikováno v:
Europe PubMed Central
Recently, we found that high levels of clotting factor VIII (150 IU/dl) are common and make an important contribution to thrombotic risk. The determinants of high factor VIII:C are unclear and might be partly genetic. Therefore, we tested the influen
Autor:
Da, Lane, Pm, Mannucci, Ka, Bauer, Rm, Bertina, Np, Bochkov, Boulyjenkov V, Chandy M, Bjorn Dahlback, Ek, Ginter, Jp, Miletich, Fr, Rosendaal, Seligsohn U
Publikováno v:
Europe PubMed Central
Autor:
Rp, Lensen, Fr, Rosendaal, Koster T, Cf, Allaart, de Ronde H, Jan P Vandenbroucke, Ph, Reitsma, Rm, Bertina
Publikováno v:
Europe PubMed Central
Both activated protein C (APC) resistance and protein C deficiency are associated with an increased risk for venous thrombosis. To assess their tendencies to venous thrombosis, we compared the median age of first venous thromboembolism in patients wi
Publikováno v:
Europe PubMed Central
The recent discovery of the factor V Leiden mutation as the molecular defect in the large majority of APC-resistant individuals, has drastically changed our view on familial thrombophilia and it has contributed to a better understanding of the intera
Publikováno v:
Europe PubMed Central
Protein S is a vitamin K-dependent plasma protein that functions as a cofactor of activated protein C (APC) in the inactivation of coagulation factors Va and VIIIa. Protein S, migrates as a doublet on reduced SDS polyacrylamide gel electrophoresis. T